Skip to content
Search

Latest Stories

UK competition watchdog to investigate PCR Covid test price

The UK’s competition watchdog said on Thursday (August 12) it would investigate the price of PCR Covid tests ‘immediately’ and help the government in taking action against testing companies if they were found breaching consumer law.

Health Secretary Sajid Javid had written to the Competition and Markets Authority (CMA) on August 6 asking it to look into the market for PCR tests to ensure that consumers did not face unnecessarily high charges or poor service.


The CMA said in a statement that it was exploring if individual PCR providers were breaching their obligations under consumer law, and if there were structural problems in the market for PCR tests that could affect price or reliability.

It would also examine if there was any immediate action that the government could take in the meantime.

George Lusty, CMA Senior Director for Consumer Protection, said: “It is essential that people paying for PCR tests are treated fairly, get what they pay for and that their rights are respected when things go wrong. We will not hesitate to take enforcement action if we find evidence that PCR providers are breaching consumer law.

“We are also working closely with DHSC to get the data we need to identify the cause of any wider problems in the PCR testing market, and to ground our advice on what action may be needed.”

For international travel during the coronavirus pandemic, the UK has divided countries in three categories, with low-risk countries rated green for quarantine-free travel, medium risk countries rated amber, and red countries requiring arrivals to spend 10 days in isolation in a hotel.

Tests cost about £75 per person on average but there are reports of some being offered for as little as £20, and others more than £500.

All travellers from countries on the green and amber lists must book a test to be taken two days after they arrive in Britain.

Earlier, the CMA had said it would respond to Javid’s request “within a month”, which sparked an angry reaction from travel industry and people.

“...we welcome the opportunity to explore issues in the PCR testing market in more depth. We recognise that this is a very live issue, impacting consumer now, so we will tailor our work to allow us to respond within the next month,” CMA Chief Executive Andrea Coscelli CBE said in a letter addressed to the Health Secretary Sajid Javid on August 10.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less